This inventor holds 28 USPTO granted patents and 1 EPO patent, primarily in Ocular Pharmacology. Top assignees: Kabi Pharmacia Ab, Pharmacia Aktiebolag, Pharmacia & Upjohn Aktiebolag. Active years: 1990-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Upsala, SE (1993 - 1998)
- Uppsala, SE (1990 - 2009)
Company Filing History:
6 out of 27 
6 out of 34 
4 out of 47 
Years Active: 1990-2009
Areas of Expertise:
Title: Johan W. Stjernschantz: Pioneering Innovations in Ear and Eye Health
Introduction
Johan W. Stjernschantz is an esteemed inventor based in Uppsala, Sweden, who boasts an impressive portfolio of 28 patents. His innovations are primarily focused on advancing treatments for ear and eye conditions, showcasing his commitment to improving patient care through scientific breakthroughs.
Latest Patents
Stjernschantz's most recent inventions include two groundbreaking patents. The first patent details a method and compositions for the local treatment of Meniere's disease, tinnitus, and/or hearing loss. This innovative treatment involves administering a therapeutically effective amount of a prostaglandin of the F-type directly to the inner ear. The method can be applied either continuously or intermittently, utilizing pumps, gels, or slow-release drug inserts to enhance efficacy.
The second patent revolves around ophthalmological compositions for the topical treatment of glaucoma or ocular hypertension. This invention comprises an effective intraocular pressure-reducing amount of a prostaglandin derivative, formulated in an ophthalmologically compatible carrier. The patent outlines the preparation methods for these compositions and their intended use, promising to revolutionize glaucoma management.
Career Highlights
Throughout his career, Stjernschantz has contributed significantly to the pharmaceutical industry, with notable stints at Kabi Pharmacia AB and Pharmacia Aktiebolag. His work emphasizes the importance of innovation in addressing critical health challenges, particularly in the fields of otology and ophthalmology.
Collaborations
Stjernschantz has collaborated with prominent professionals in his field, including Bahram Resul and Laszlo Z. Bito. These partnerships have fostered a creative environment, enabling the development of cutting-edge solutions that address complex medical issues.
Conclusion
Johan W. Stjernschantz's dedication to innovation in the medical field, particularly concerning ear and eye health, is evident in his extensive patent record. His latest breakthroughs in the treatment of Meniere's disease, tinnitus, and glaucoma highlight the potential of targeted therapies to enhance patient outcomes. Stjernschantz continues to pave the way for future advancements in medical technology through his relentless pursuit of knowledge and improvement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile